Seyed Hossein Shahcheraghi | Molecular Pharmacology | Innovative Molecular Biologist Award

Innovative Molecular Biologist Award

Seyed Hossein Shahcheraghi
Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran

Seyed Hossein Shahcheraghi
Affiliation Yazd Shahid Sadoughi University of Medical Sciences Campus
Country Iran
Scopus ID 55935316300
Documents 75
Citations 820
h-index 13
Subject Area Molecular Pharmacology
Event International Molecular Biologist Awards
ORCID 0000-0003-1399-5222

Seyed Hossein Shahcheraghi is a researcher affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran, with a stated subject-area focus in molecular pharmacology. These bibliometric indicators provide a quantitative overview of the research record and are presented here as profile information rather than as an independent assessment of scientific quality.[1] [2]

Abstract

This academic recognition profile presents the research record of Seyed Hossein Shahcheraghi, affiliated with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran. The stated research subject area is molecular pharmacology, a field concerned with molecular and cellular mechanisms underlying pharmacological activity, drug action, and therapeutic response. The available Scopus profile reports 75 documents, 820 citations, and an h-index of 13.[1] The profile is additionally associated with ORCID identifier 0000-0003-1399-5222.[2] On the basis of the supplied bibliometric information and stated research area, the researcher is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards.

Keywords

Keywords: Seyed Hossein Shahcheraghi; Molecular Pharmacology; Molecular Biology; Pharmacology; Biomedical Research; Research Impact; Bibliometrics; Scopus; ORCID; Innovative Molecular Biologist Award.

Introduction

Molecular pharmacology examines pharmacological phenomena at the molecular and cellular levels, linking biological mechanisms with the actions of drugs and other bioactive compounds. Modern pharmacological research increasingly incorporates molecular targets, signaling pathways, cellular responses, and mechanisms that influence therapeutic activity. The identification and characterization of molecular targets are consequently important components of contemporary drug discovery and pharmacological investigation.[4]

Within this broader scientific context, the research profile of Seyed Hossein Shahcheraghi is identified with molecular pharmacology and is associated with Yazd Shahid Sadoughi University of Medical Sciences Campus in Iran. The bibliographic indicators supplied for the profile provide a measurable description of publication activity and citation influence within indexed scholarly literature.[1]

Research Profile

The researcher’s stated subject area is Molecular Pharmacology. The supplied Scopus information identifies the researcher with Author ID 55935316300 and records 75 documents, 820 citations, and an h-index of 13.[1] These values are bibliometric descriptors of the indexed research record and may change as additional publications and citations are incorporated into bibliographic databases.

  • Researcher: Seyed Hossein Shahcheraghi
  • Institution: Yazd Shahid Sadoughi University of Medical Sciences Campus
  • Country: Iran
  • Primary subject area: Molecular Pharmacology
  • Scopus documents: 75
  • Scopus citations: 820
  • h-index: 13
  • ORCID: 0000-0003-1399-5222

The ORCID identifier provides a persistent researcher identifier intended to support reliable attribution of scholarly works and distinguish researchers across systems.[2] Used alongside bibliographic identifiers such as Scopus Author ID, persistent identifiers can assist in organizing and validating scholarly records.

Research Contributions

The available information places Shahcheraghi’s research within molecular pharmacology. At this level of description, the most appropriate characterization is a field-based one rather than a claim concerning a particular molecular pathway, therapeutic target, disease model, or individual discovery, because those details are not specified in the supplied researcher profile.

Molecular pharmacology encompasses the study of interactions between pharmacologically active molecules and biological systems. Research in this area may connect molecular targets with cellular mechanisms and pharmacological outcomes, contributing to the broader understanding of drug action and therapeutic development.[4] The researcher’s stated subject-area classification therefore provides the principal basis for describing the scientific domain represented in this recognition profile.

Publications

The supplied bibliometric record reports 75 documents indexed under the researcher’s Scopus Author ID. This publication count represents the document total provided for the profile at the time of preparation and should be understood as a database-derived indicator rather than a complete independent bibliography of every scholarly work associated with the researcher.[1]

A publication-level assessment would ordinarily examine article titles, journals, publication dates, co-authorship, citation patterns, research topics, and persistent identifiers such as DOI records. No individual publication list or researcher-specific DOI information was supplied for this page; therefore, no specific article is attributed to Shahcheraghi without an independently verified bibliographic record.

Research Impact

The supplied Scopus profile reports 820 citations and an h-index of 13.[1] Citation counts provide one quantitative measure of how frequently indexed scholarly documents have been cited, while the h-index combines publication and citation information into a single bibliometric indicator. Such measures are useful for describing research visibility but do not, by themselves, establish the quality, originality, or practical significance of individual research contributions.

The reported document and citation figures provide a quantitative basis for recognizing an established publication record within indexed literature. They should nevertheless be interpreted in relation to disciplinary practices, publication age, database coverage, authorship patterns, and other qualitative evidence when making a comprehensive assessment of research influence.

Award Suitability

The profile is presented in connection with the Innovative Molecular Biologist Award under the International Molecular Biologist Awards. The stated field of Molecular Pharmacology provides a direct connection to molecular-level biological research, while the reported Scopus record supplies quantitative evidence of sustained scholarly publication and citation activity.[1]

On the information provided, the recognition profile can be framed around three principal elements: an identified academic affiliation, a defined molecular pharmacology subject area, and a documented bibliometric record. The award suitability statement is therefore descriptive of the supplied profile and does not constitute an independent peer-review judgment or a claim of comparative superiority over other researchers.

Conclusion

Seyed Hossein Shahcheraghi is identified with Yazd Shahid Sadoughi University of Medical Sciences Campus, Iran, and with the research area of Molecular Pharmacology. The supplied Scopus profile reports 75 documents, 820 citations, and an h-index of 13, while ORCID provides the persistent identifier 0000-0003-1399-5222.[1] [2]

These identifiers and bibliometric indicators establish the principal factual basis of this academic recognition page. In the context of the International Molecular Biologist Awards, the profile supports presentation under the Innovative Molecular Biologist Award while maintaining a distinction between documented bibliometric information and broader qualitative judgments concerning scientific achievement.

References

  1. Elsevier. (n.d.). Scopus author details: Seyed Hossein Shahcheraghi, Author ID 55935316300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55935316300
  2. ORCID. (n.d.). Seyed Hossein Shahcheraghi — ORCID record. ORCID.
    https://orcid.org/0000-0003-1399-5222
  3. International Molecular Biologist Awards. (n.d.). International Molecular Biologist Awards.
    https://molecularbiologist.org/
  4. Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., & Overington, J. P. (2017). A comprehensive map of molecular drug targets. Nature Reviews Drug Discovery, 16, 19–34.
    https://doi.org/10.1038/nrd.2016.230
  5. Molecular pharmacology and drug-target research. DOI-linked scholarly literature concerning molecular drug targets and pharmacological mechanisms.
    https://doi.org/10.1038/nrd.2016.116

Danyelle Townsend | Molecular Pharmacology | Innovative Research Award

Innovative Research Award

Danyelle Townsend
Medical University of South Carolina, United States

Danyelle Townsend
Affiliation Medical University of South Carolina
Country United States
Scopus ID 7202240755
Documents 173
Citations 14,308
h-index 53
Subject Area Molecular Pharmacology
Event International Molecular Biologist Awards
Google Scholar ID zaTtq2UAAAAJ

Danyelle Townsend is a molecular pharmacology researcher recognized for contributions in understanding biochemical mechanisms associated with cellular defense, drug response, and human disease. Her academic work has focused on glutathione metabolism, detoxification pathways, and molecular factors influencing therapeutic outcomes. This article presents a scholarly overview of her research profile and recognition through the Innovative Research Award.

Abstract

The research profile of Danyelle Townsend reflects sustained investigation into molecular pharmacology, particularly the biological roles of glutathione-related pathways. Her studies have contributed to broader understanding of oxidative stress, cancer biology, and cellular protection mechanisms. Key publications have examined glutathione functions and drug resistance processes. [1]

Keywords

Molecular Pharmacology; Glutathione; Cancer Research; Drug Resistance; Oxidative Stress; Biomedical Science.

Introduction

Molecular pharmacology investigates interactions between biological systems and therapeutic compounds. Research in this field provides insight into disease mechanisms and supports development of improved treatment strategies. Townsend’s work has emphasized molecular pathways that regulate cellular responses to environmental and therapeutic challenges. [2]

Research Profile

Danyelle Townsend is affiliated with the Medical University of South Carolina and has developed expertise in molecular mechanisms associated with pharmacological responses. Her scholarly record includes 173 documents, 14,308 citations, and an h-index of 53, demonstrating notable engagement within biomedical research literature.

Research Contributions

Major contributions include investigations into glutathione metabolism, glutathione-S-transferase activity, and molecular pathways affecting cancer therapy. These studies have provided evidence regarding antioxidant defense and mechanisms involved in therapeutic resistance. [3]

Publications

  • The importance of glutathione in human disease, 2003.
  • The role of glutathione-S-transferase in anti-cancer drug resistance, 2003.
  • Glutathione S-transferase polymorphisms: cancer incidence and therapy, 2006.

Research Impact

The impact of this research is reflected through citation activity and continued relevance of molecular detoxification pathways in biomedical science. The findings support ongoing investigations into personalized medicine and therapeutic optimization.

Award Suitability

The Innovative Research Award recognizes researchers whose work demonstrates scientific contribution, methodological advancement, and meaningful influence within their discipline. Townsend’s publication record and research focus align with these academic criteria.

Conclusion

Danyelle Townsend’s research represents sustained contributions to molecular pharmacology through studies of cellular defense mechanisms, drug resistance, and disease-related biochemical processes.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: Danyelle Townsend, Author ID 7202240755. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7202240755
  2. Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene. 2003;22:7369–7375.
  3. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomedicine & Pharmacotherapy. 2003;57:145–155.
    DOI: https://doi.org/10.1016/S0753-3322(03)00022-0
  4. Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and seleno-compounds. Biomedicine & Pharmacotherapy. 2003;57:134–144.
  5. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene. 2006;25:1639–1648.